Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Data concerning secondary structure and alpha-glucans-binding capacity of the LaCBM26.

Armenta S, Sánchez-Cuapio Z, Farrés A, Manoutcharian K, Hernandez-Santoyo A, Sánchez S, Rodríguez-Sanoja R.

Data Brief. 2018 Nov 14;21:1944-1949. doi: 10.1016/j.dib.2018.11.056. eCollection 2018 Dec.

2.

Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries.

Servín-Blanco R, Chávaro-Ortiz RM, Zamora-Alvarado R, Martínez-Cortes F, Gevorkian G, Manoutcharian K.

Immunol Lett. 2018 Dec;204:47-54. doi: 10.1016/j.imlet.2018.10.008. Epub 2018 Oct 16.

PMID:
30339819
3.

The role of conserved non-aromatic residues in the Lactobacillus amylovorus α-amylase CBM26-starch interaction.

Armenta S, Sánchez-Cuapio Z, Munguia ME, Pulido NO, Farrés A, Manoutcharian K, Hernandez-Santoyo A, Moreno-Mendieta S, Sánchez S, Rodríguez-Sanoja R.

Int J Biol Macromol. 2019 Jan;121:829-838. doi: 10.1016/j.ijbiomac.2018.10.061. Epub 2018 Oct 15.

PMID:
30336243
4.

GK-1 peptide reduces tumor growth, decreases metastatic burden, and increases survival in a murine breast cancer model.

Torres-García D, Pérez-Torres A, Manoutcharian K, Orbe U, Servín-Blanco R, Fragoso G, Sciutto E.

Vaccine. 2017 Oct 9;35(42):5653-5661. doi: 10.1016/j.vaccine.2017.08.060. Epub 2017 Sep 7.

PMID:
28890195
5.

Recombinant Antibody Fragments for Neurodegenerative Diseases.

Manoutcharian K, Perez-Garmendia R, Gevorkian G.

Curr Neuropharmacol. 2017;15(5):779-788. doi: 10.2174/1570159X01666160930121647. Review.

6.

Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.

Servín-Blanco R, Zamora-Alvarado R, Gevorkian G, Manoutcharian K.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2640-2648. doi: 10.1080/21645515.2016.1191718. Epub 2016 Jun 13. Review.

7.

Injected phage-displayed-VP28 vaccine reduces shrimp Litopenaeus vannamei mortality by white spot syndrome virus infection.

Solís-Lucero G, Manoutcharian K, Hernández-López J, Ascencio F.

Fish Shellfish Immunol. 2016 Aug;55:401-6. doi: 10.1016/j.fsi.2016.05.027. Epub 2016 May 27.

PMID:
27241285
8.

Variable epitope library carrying heavily mutated survivin-derived CTL epitope variants as a new class of efficient vaccine immunogen tested in a mouse model of breast cancer.

NoeDominguez-Romero A, Zamora-Alvarado R, Servín-Blanco R, Pérez-Hernández EG, Castrillon-Rivera LE, Munguia ME, Acero G, Govezensky T, Gevorkian G, Manoutcharian K.

Hum Vaccin Immunother. 2014;10(11):3201-13. doi: 10.4161/hv.29679.

9.

Concomitant treatment with pertussis toxin plus temozolomide increases the survival of rats bearing intracerebral RG2 glioma.

Magaña-Maldonado R, Manoutcharian K, Hernández-Pedro NY, Rangel-López E, Pérez-De la Cruz V, Rodríguez-Balderas C, Sotelo J, Pineda B.

J Cancer Res Clin Oncol. 2014 Feb;140(2):291-301. doi: 10.1007/s00432-013-1565-3. Epub 2013 Dec 14.

PMID:
24337403
10.

Amyloid-β peptide binds to cytochrome C oxidase subunit 1.

Hernandez-Zimbron LF, Luna-Muñoz J, Mena R, Vazquez-Ramirez R, Kubli-Garfias C, Cribbs DH, Manoutcharian K, Gevorkian G.

PLoS One. 2012;7(8):e42344. doi: 10.1371/journal.pone.0042344. Epub 2012 Aug 21.

11.

Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response.

Charles-Niño C, Pedroza-Roldan C, Viveros M, Gevorkian G, Manoutcharian K.

Vaccine. 2011 Jul 18;29(32):5313-21. doi: 10.1016/j.vaccine.2011.05.007. Epub 2011 May 19.

PMID:
21600948
12.

Recombinant S3Pvac-phage anticysticercosis vaccine: Simultaneous protection against cysticercosis and hydatid disease in rural pigs.

Morales J, de Aluja AS, Martínez JJ, Hernández M, Rosas G, Villalobos N, Hernández B, Blancas A, Manoutcharian K, Gevorkian G, Cervantes J, Díaz A, Fleury A, Fragoso G, Larralde C, Sciutto E.

Vet Parasitol. 2011 Feb 28;176(1):53-8. doi: 10.1016/j.vetpar.2010.10.039. Epub 2010 Oct 27.

PMID:
21251758
13.

Isolation of neurocysticercosis-related antigens from a genomic phage display library of Taenia solium.

González E, Robles Y, Govezensky T, Bobes RJ, Gevorkian G, Manoutcharian K.

J Biomol Screen. 2010 Dec;15(10):1268-73. doi: 10.1177/1087057110385229. Epub 2010 Oct 25.

PMID:
20974903
14.

Anti-11[E]-pyroglutamate-modified amyloid β antibodies cross-react with other pathological Aβ species: relevance for immunotherapy.

Perez-Garmendia R, Ibarra-Bracamontes V, Vasilevko V, Luna-Muñoz J, Mena R, Govezensky T, Acero G, Manoutcharian K, Cribbs DH, Gevorkian G.

J Neuroimmunol. 2010 Dec 15;229(1-2):248-55. doi: 10.1016/j.jneuroim.2010.08.020. Epub 2010 Sep 22.

15.

Novel amyloid-beta specific scFv and VH antibody fragments from human and mouse phage display antibody libraries.

Medecigo M, Manoutcharian K, Vasilevko V, Govezensky T, Munguia ME, Becerril B, Luz-Madrigal A, Vaca L, Cribbs DH, Gevorkian G.

J Neuroimmunol. 2010 Jun;223(1-2):104-14. doi: 10.1016/j.jneuroim.2010.03.023. Epub 2010 May 6.

16.

Variable epitope library-based vaccines: shooting moving targets.

Pedroza-Roldan C, Charles-Niño C, Saavedra R, Govezensky T, Vaca L, Avaniss-Aghajani E, Gevorkian G, Manoutcharian K.

Mol Immunol. 2009 Dec;47(2-3):270-82. doi: 10.1016/j.molimm.2009.09.024. Epub 2009 Oct 23.

PMID:
19853920
17.

Immunodominant epitope and properties of pyroglutamate-modified Abeta-specific antibodies produced in rabbits.

Acero G, Manoutcharian K, Vasilevko V, Munguia ME, Govezensky T, Coronas G, Luz-Madrigal A, Cribbs DH, Gevorkian G.

J Neuroimmunol. 2009 Aug 18;213(1-2):39-46. doi: 10.1016/j.jneuroim.2009.06.003. Epub 2009 Jul 9.

18.

Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.

Morales J, Martínez JJ, Manoutcharian K, Hernández M, Fleury A, Gevorkian G, Acero G, Blancas A, Toledo A, Cervantes J, Maza V, Quet F, Bonnabau H, de Aluja AS, Fragoso G, Larralde C, Sciutto E.

Vaccine. 2008 Jun 2;26(23):2899-905. doi: 10.1016/j.vaccine.2008.03.042. Epub 2008 Apr 10.

PMID:
18440675
19.

Amyloid-beta peptide binds to microtubule-associated protein 1B (MAP1B).

Gevorkian G, Gonzalez-Noriega A, Acero G, Ordoñez J, Michalak C, Munguia ME, Govezensky T, Cribbs DH, Manoutcharian K.

Neurochem Int. 2008 May;52(6):1030-6. Epub 2007 Nov 12.

20.

Epitope mapping and neuroprotective properties of a human single chain FV antibody that binds an internal epitope of amyloid-beta 1-42.

Solórzano-Vargas RS, Vasilevko V, Acero G, Ugen KE, Martinez R, Govezensky T, Vazquez-Ramirez R, Kubli-Garfias C, Cribbs DH, Manoutcharian K, Gevorkian G.

Mol Immunol. 2008 Feb;45(4):881-6. Epub 2007 Sep 24.

PMID:
17889938
21.

Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine.

Sciutto E, Rosas G, Hernández M, Morales J, Cruz-Revilla C, Toledo A, Manoutcharian K, Gevorkian G, Blancas A, Acero G, Hernández B, Cervantes J, Bobes RJ, Goldbaum FA, Huerta M, Diaz-Orea A, Fleury A, de Aluja AS, Cabrera-Ponce JL, Herrera-Estrella L, Fragoso G, Larralde C.

Vaccine. 2007 Feb 9;25(8):1368-78. Epub 2006 Oct 23. Review.

PMID:
17188784
22.

Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico.

Sciutto E, Morales J, Martínez JJ, Toledo A, Villalobos MN, Cruz-Revilla C, Meneses G, Hernández M, Díaz A, Rodarte LF, Acero G, Gevorkian G, Manoutcharian K, Paniagua J, Fragoso G, Fleury A, Larralde R, De Aluja AS, Larralde C.

Parasitology. 2007 Jan;134(Pt 1):129-33. Epub 2006 Sep 4.

PMID:
16948875
23.

Identification of amyloid-beta 1-42 binding protein fragments by screening of a human brain cDNA library.

Munguia ME, Govezensky T, Martinez R, Manoutcharian K, Gevorkian G.

Neurosci Lett. 2006 Apr 10-17;397(1-2):79-82. Epub 2005 Dec 27.

PMID:
16384638
24.

Isolation of the Taenia crassiceps antigens from a phage display cDNA library and evaluation of their use for diagnosis of neurocysticercosis.

Robles Y, González E, Govezensky T, Mungia ME, Acero G, Bobes RJ, Gevorkian G, Manoutcharian K.

Clin Immunol. 2005 Sep;116(3):265-70.

PMID:
15905129
25.

Bacteriophages as tools for vaccine and drug development.

Manoutcharian K.

Expert Rev Vaccines. 2005 Feb;4(1):5-7. No abstract available.

PMID:
15757465
26.

Peptide mimotopes of Mycobacterium tuberculosis carbohydrate immunodeterminants.

Gevorkian G, Segura E, Acero G, Palma JP, Espitia C, Manoutcharian K, López-Marín LM.

Biochem J. 2005 Apr 15;387(Pt 2):411-7.

27.

Mimotopes of conformational epitopes in fibrillar beta-amyloid.

Gevorkian G, Petrushina I, Manoutcharian K, Ghochikyan A, Acero G, Vasilevko V, Cribbs DH, Agadjanyan MG.

J Neuroimmunol. 2004 Nov;156(1-2):10-20.

PMID:
15465592
28.

Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.

Cano A, Viveros M, Acero G, Govezensky T, Munguia ME, Gonzalez E, Soto L, Gevorkian G, Manoutcharian K.

Immunol Lett. 2004 Sep;95(2):207-12.

PMID:
15388262
29.

Human single chain Fv antibodies and a complementarity determining region-derived peptide binding to amyloid-beta 1-42.

Manoutcharian K, Acero G, Munguia ME, Becerril B, Massieu L, Govezensky T, Ortiz E, Marks JD, Cao C, Ugen K, Gevorkian G.

Neurobiol Dis. 2004 Oct;17(1):114-21.

PMID:
15350972
30.

Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis.

Manoutcharian K, Díaz-Orea A, Gevorkian G, Fragoso G, Acero G, González E, De Aluja A, Villalobos N, Gómez-Conde E, Sciutto E.

Vet Immunol Immunopathol. 2004 May;99(1-2):11-24.

PMID:
15113650
31.

Amyloid-beta peptide-specific single chain Fv antibodies isolated from an immune phage display library.

Manoutcharian K, Acero G, Munguia ME, Montero JA, Govezensky T, Cao C, Ugen K, Gevorkian G.

J Neuroimmunol. 2003 Dec;145(1-2):12-7.

PMID:
14644026
32.

Phage-displayed mimotopes recognizing a biologically active anti-HIV-1 gp120 murine monoclonal antibody.

Gómez-Román VR, Cao C, Bai Y, Santamaría H, Acero G, Manoutcharian K, Weiner DB, Ugen KE, Gevorkian G.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):147-53.

PMID:
12394792
33.

New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis.

Sciutto E, Fragoso G, Manoutcharian K, Gevorkian G, Rosas-Salgado G, Hernández-Gonzalez M, Herrera-Estrella L, Cabrera-Ponce J, López-Casillas F, González-Bonilla C, Santiago-Machuca A, Ruíz-Pérez F, Sánchez J, Goldbaum F, Aluja A, Larralde C.

Arch Med Res. 2002 Jul-Aug;33(4):371-8. Review.

PMID:
12234527
34.

Identification of peptide sequences specific for serum antibodies from human papillomavirus-infected patients using phage display libraries.

Santamaria H, Manoutcharian K, Rocha L, Gonzalez E, Acero G, Govezensky T, Uribe LI, Olguin A, Paniagua J, Gevorkian G.

Clin Immunol. 2001 Dec;101(3):296-302.

PMID:
11726222
35.

Phage displayed biomolecules as preventive and therapeutic agents.

Manoutcharian K, Gevorkian G, Cano A, Almagro JC.

Curr Pharm Biotechnol. 2001 Sep;2(3):217-23. Review.

PMID:
11530876
36.

Intraspleen DNA inoculation elicits protective cellular immune responses.

Cano A, Fragoso G, Gevorkian G, Terrazas LI, Petrossian P, Govezensky T, Sciutto E, Manoutcharian K.

DNA Cell Biol. 2001 Apr;20(4):215-21.

PMID:
11403718
37.

Identification of mimotopes of platelet autoantigens associated with autoimmune thrombocytopenic purpura.

Gevorkian G, Manoutcharian K, Govezensky T, Cano JA, Dominguez V, Santamaria H, Larralde C.

J Autoimmun. 2000 Aug;15(1):33-40.

PMID:
10936026
38.

DNA pulsed macrophage-mediated cDNA expression library immunization in vaccine development.

Manoutcharian K, Terrazas LI, Gevorkian G, Govezensky T.

Vaccine. 1999 Oct 14;18(5-6):389-91.

PMID:
10519926
39.

Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementarity-determining regions: an effective vaccine design tested in murine cysticercosis.

Manoutcharian K, Terrazas LI, Gevorkian G, Acero G, Petrossian P, Rodriguez M, Govezensky T.

Infect Immun. 1999 Sep;67(9):4764-70.

40.

Towards a Taenia solium cysticercosis vaccine: an epitope shared by Taenia crassiceps and Taenia solium protects mice against experimental cysticercosis.

Toledo A, Larralde C, Fragoso G, Gevorkian G, Manoutcharian K, Hernández M, Acero G, Rosas G, López-Casillas F, Garfias CK, Vázquez R, Terrazas I, Sciutto E.

Infect Immun. 1999 May;67(5):2522-30.

41.

Characterization of cerebrospinal fluid antibody specificities in neurocysticercosis using phage display peptide library.

Manoutcharian K, Sotelo J, Garcia E, Cano A, Gevorkian G.

Clin Immunol. 1999 Apr;91(1):117-21.

PMID:
10219262
42.

Protection against murine cysticercosis using cDNA expression library immunization.

Manoutcharian K, Terrazas LI, Gevorkian G, Govezensky T.

Immunol Lett. 1998 Jul;62(3):131-6.

PMID:
9698110
43.

Identification of autoimmune thrombocytopenic purpura-related epitopes using phage-display peptide library.

Gevorkian G, Manoutcharian K, Almagro JC, Govezensky T, Dominguez V.

Clin Immunol Immunopathol. 1998 Mar;86(3):305-9.

PMID:
9557164
44.

Cysticercosis: identification and cloning of protective recombinant antigens.

Manoutcharian K, Rosas G, Hernandez M, Fragoso G, Aluja A, Villalobos N, Rodarte LF, Sciutto E.

J Parasitol. 1996 Apr;82(2):250-4.

PMID:
8604092
45.

Immunodominant synthetic peptides of Taenia crassiceps in murine and human cysticercosis.

Gevorkian G, Manoutcharian K, Larralde C, Hernandez M, Almagro JC, Viveros M, Sotelo J, Garcia E, Sciutto E.

Immunol Lett. 1996 Mar;49(3):185-9.

PMID:
8739315

Supplemental Content

Loading ...
Support Center